603077 和邦生物
已收盘 05-11 15:00:00
资讯
新帖
简况
每周股票复盘：和邦生物（603077）为子公司担保2亿元
证券之星 · 05-10 02:48
每周股票复盘：和邦生物（603077）为子公司担保2亿元
和邦生物（603077）披露集中竞价减持已回购股份进展公告，5月6日股价上涨0.34%
证券之星 · 05-06
和邦生物（603077）披露集中竞价减持已回购股份进展公告，5月6日股价上涨0.34%
每周股票复盘：和邦生物（603077）控股股东质押2.2亿股用于经营
证券之星 · 05-02
每周股票复盘：和邦生物（603077）控股股东质押2.2亿股用于经营
和邦生物（603077）披露控股股东部分股份质押公告，4月28日股价下跌1.35%
证券之星 · 04-28
和邦生物（603077）披露控股股东部分股份质押公告，4月28日股价下跌1.35%
每周股票复盘：和邦生物（603077）股东户数增36.39%，净利润同比大增
证券之星 · 04-26
每周股票复盘：和邦生物（603077）股东户数增36.39%，净利润同比大增
和邦生物（603077）2026年一季报简析：净利润同比增长1286.79%，三费占比上升明显
证券之星 · 04-22
和邦生物（603077）2026年一季报简析：净利润同比增长1286.79%，三费占比上升明显
和邦生物(603077)3月31日股东户数27.52万户，较上期增加36.39%
证券之星 · 04-21
和邦生物(603077)3月31日股东户数27.52万户，较上期增加36.39%
和邦生物(603077.SH)：部分产品生产线技改
中金财经 · 04-21
和邦生物(603077.SH)：部分产品生产线技改
图解和邦生物一季报：第一季度单季净利润同比增长1286.79%
证券之星 · 04-21
图解和邦生物一季报：第一季度单季净利润同比增长1286.79%
和邦生物（603077）发布董事、高级管理人员薪酬管理制度，4月20日股价上涨4.49%
证券之星 · 04-20
和邦生物（603077）发布董事、高级管理人员薪酬管理制度，4月20日股价上涨4.49%
和邦生物最新公告：2025年净亏损5.36亿元同比由盈转亏
证券之星 · 04-20
和邦生物最新公告：2025年净亏损5.36亿元同比由盈转亏
和邦生物最新公告：拟投77.47亿元建设年产60万吨蛋氨酸项目
证券之星 · 04-20
和邦生物最新公告：拟投77.47亿元建设年产60万吨蛋氨酸项目
和邦生物最新公告：一季度净利润同比增长1287%蛋氨酸产、销量增加
证券之星 · 04-20
和邦生物最新公告：一季度净利润同比增长1287%蛋氨酸产、销量增加
每周股票复盘：和邦生物（603077）推7.91亿员工持股计划
证券之星 · 04-19
每周股票复盘：和邦生物（603077）推7.91亿员工持股计划
4月16日和邦生物现4101.45万元大宗交易
证券之星 · 04-16
4月16日和邦生物现4101.45万元大宗交易
和邦生物（603077）披露2026年第一次临时股东会决议公告，4月15日股价下跌1.99%
证券之星 · 04-15
和邦生物（603077）披露2026年第一次临时股东会决议公告，4月15日股价下跌1.99%
每周股票复盘：和邦生物（603077）担保总额达68亿
证券之星 · 04-05
每周股票复盘：和邦生物（603077）担保总额达68亿
和邦生物（603077）披露集中竞价减持已回购股份进展公告，4月2日股价下跌2.14%
证券之星 · 04-02
和邦生物（603077）披露集中竞价减持已回购股份进展公告，4月2日股价下跌2.14%
和邦生物(603077.SH)：减持2340万股已回购股份
中金财经 · 04-01
和邦生物(603077.SH)：减持2340万股已回购股份
每周股票复盘：和邦生物（603077）控股股东质押247百万股用于经营
证券之星 · 03-29
每周股票复盘：和邦生物（603077）控股股东质押247百万股用于经营
加载更多
公司概况
公司名称：
四川和邦生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2012-07-31
主营业务：
四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是联碱产品、矿产品、双甘膦/草甘膦、玻璃及光伏业务、蛋氨酸及副产品、生物农药、零售成品油、液氨、硫酸铵、天然气。
发行价格：
17.50
{"stockData":{"symbol":"603077","market":"SH","secType":"STK","nameCN":"和邦生物","latestPrice":2.87,"timestamp":1778482802000,"preClose":2.89,"halted":0,"volume":224431360,"delay":0,"changeRate":-0.0069,"floatShares":8832000000,"shares":8832000000,"eps":-0.0425,"marketStatus":"已收盘","change":-0.02,"latestTime":"05-11 15:00:00","open":2.89,"high":2.92,"low":2.85,"amount":647000000,"amplitude":0.0242,"askPrice":2.87,"askSize":13634,"bidPrice":2.86,"bidSize":79913,"shortable":0,"etf":0,"ttmEps":-0.0425,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778549400000},"marketStatusCode":5,"adr":0,"adjPreClose":2.89,"symbolType":"stock","openAndCloseTimeList":[[1778463000000,1778470200000],[1778475600000,1778482800000]],"highLimit":3.18,"lowLimit":2.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":8831698228,"isCdr":false,"pbRate":1.43,"roa":"--","roe":"0.966%","epsLYR":-0.0672,"committee":-0.007147,"marketValue":25347000000,"turnoverRate":0.0254,"status":1,"floatMarketCap":25347000000},"requestUrl":"/m/hq/s/603077","defaultTab":"news","newsList":[{"id":"2634414469","title":"每周股票复盘：和邦生物（603077）为子公司担保2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634414469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634414469?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:48","pubTimestamp":1778352491,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，和邦生物报收于2.89元，较上周的2.96元下跌2.36%。本周关注点公司公告汇总：和邦生物为子公司武骏光能提供2亿元连带责任保证担保。截至2026年3月31日，公司及子公司对外担保总额为68.07亿元，占最近一期经审计净资产的38.08%，无逾期担保。和邦生物关于集中竞价减持已回购股份的进展公告四川和邦生物科技股份有限公司于2024年4月至8月期间通过集中竞价交易方式累计回购股份227,027,340股，占公司总股本的2.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","603077","BK0196","BK0132","BK0077","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633131694","title":"和邦生物（603077）披露集中竞价减持已回购股份进展公告，5月6日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633131694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633131694?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:13","pubTimestamp":1778076795,"startTime":"0","endTime":"0","summary":"近日，和邦生物发布《关于集中竞价减持已回购股份的进展公告》。公告显示，公司于2024年4月至8月期间通过集中竞价交易方式累计回购股份227,027,340股，占公司总股本的2.57%。为补充项目流动资金，公司于2026年1月30日披露减持计划，拟在2026年3月2日至9月1日期间通过集中竞价交易方式减持不超过176,630,744股已回购股份，减持比例不超过公司总股本的2%。截至2026年4月30日，公司已减持88,315,000股，占总股本的1.00%，成交均价为3.01元/股，减持金额为265,785,700.04元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600039658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","603077","BK0132","BK0229","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632496426","title":"每周股票复盘：和邦生物（603077）控股股东质押2.2亿股用于经营","url":"https://stock-news.laohu8.com/highlight/detail?id=2632496426","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632496426?lang=zh_cn&edition=full","pubTime":"2026-05-02 01:35","pubTimestamp":1777656913,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，和邦生物报收于2.96元，较上周的2.93元上涨1.02%。本周，和邦生物4月30日盘中最高价报3.07元。本周关注点公司公告汇总：控股股东和邦集团质押220,000,000股股份，占其持股总数的65.13%。公司公告汇总：本次质押后，和邦集团累计质押股份数达1,279,000,000股，占公司总股本14.48%。和邦集团及其一致行动人贺正刚先生合计持有公司股份2,376,411,103股，合计质押股份占其持股总数的53.82%。本次股份质押不会导致公司实际控制权变更，不影响公司生产经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","603077","BK0132","BK0077","BK0196","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630651583","title":"和邦生物（603077）披露控股股东部分股份质押公告，4月28日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630651583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630651583?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:05","pubTimestamp":1777385126,"startTime":"0","endTime":"0","summary":"近日，和邦生物发布《关于控股股东部分股份质押的公告》。本次质押后，和邦集团累计质押股份数量为1,279,000,000股，占其持股总数的65.13%，占公司总股本的14.48%。和邦集团及其一致行动人贺正刚先生合计持有公司股份2,376,411,103股，合计质押股份占其持股总数的53.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800063998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0132","BK0229","BK0027","603077","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630917801","title":"每周股票复盘：和邦生物（603077）股东户数增36.39%，净利润同比大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2630917801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630917801?lang=zh_cn&edition=full","pubTime":"2026-04-26 02:28","pubTimestamp":1777141692,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，和邦生物报收于2.93元，较上周的3.12元下跌6.09%。本周关注点股本股东变化：股东户数较上年末增加36.39%，户均持股数量降至3.21万股。股本股东变化截至2026年3月31日，公司股东户数为27.52万户，较2025年12月31日增加7.34万户，增幅达36.39%。四川华信会计师事务所出具内部控制审计报告，认为公司截至2025年12月31日，在所有重大方面保持了有效的财务报告内部控制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600000849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629606508","title":"和邦生物（603077）2026年一季报简析：净利润同比增长1286.79%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2629606508","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629606508?lang=zh_cn&edition=full","pubTime":"2026-04-22 06:06","pubTimestamp":1776809198,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期和邦生物发布2026年一季报。截至本报告期末，公司营业总收入13.88亿元，同比下降19.58%，归母净利润1.74亿元，同比上升1286.79%。本报告期和邦生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达38.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200011364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629081483","title":"和邦生物(603077)3月31日股东户数27.52万户，较上期增加36.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629081483","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629081483?lang=zh_cn&edition=full","pubTime":"2026-04-21 17:12","pubTimestamp":1776762725,"startTime":"0","endTime":"0","summary":"证券之星消息，近日和邦生物披露，截至2026年3月31日公司股东户数为27.52万户，较12月31日增加7.34万户，增幅为36.39%。在农化制品行业个股中，和邦生物股东户数高于行业平均水平，截至3月31日，农化制品行业平均股东户数为4.54万户。从股价来看，2025年12月31日至2026年3月31日，和邦生物区间涨幅为24.34%，在此期间股东户数增加7.34万户，增幅为36.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100038564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","603077","BK0229","BK0077","BK0196","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629857030","title":"和邦生物(603077.SH)：部分产品生产线技改","url":"https://stock-news.laohu8.com/highlight/detail?id=2629857030","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629857030?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:57","pubTimestamp":1776758222,"startTime":"0","endTime":"0","summary":"格隆汇4月21日丨和邦生物公布，受相关产品市场竞争加剧影响，为提高产品竞争力，拟对公司部分产品生产线进行技术改造升级，具体情况如下：。预计本次技改时长不超过12个月。 除上述部分产品外，公司其他产品如草甘膦、蛋氨酸、磷矿石等生产经营活动一切正常。此外，公司也将提前部署生产线复产准备工作，做好原辅材料储备、设备调试校准等前期筹备，最大限度降低本次技改对公司的影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260421/32160028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0196","BK0027","BK0132","BK0229","603077","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629973720","title":"图解和邦生物一季报：第一季度单季净利润同比增长1286.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629973720","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629973720?lang=zh_cn&edition=full","pubTime":"2026-04-21 01:22","pubTimestamp":1776705723,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物2026年一季报显示，一季度公司主营收入13.88亿元，同比下降19.58%；归母净利润1.74亿元，同比上升1286.79%；扣非净利润1.71亿元，同比上升1919.23%；负债率36.69%，投资收益-170.73万元，财务费用3063.36万元，毛利率24.37%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100003098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628729674","title":"和邦生物（603077）发布董事、高级管理人员薪酬管理制度，4月20日股价上涨4.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628729674","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628729674?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:03","pubTimestamp":1776693800,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，和邦生物报收于3.26元，较前一交易日上涨4.49%，最新总市值为287.91亿元。该股当日开盘3.12元，最高3.29元，最低3.1元，成交额达12.61亿元，换手率为4.41%。近日，四川和邦生物科技股份有限公司发布《董事、高级管理人员薪酬管理制度》。该制度明确薪酬管理原则、机构职责、薪酬结构与标准、发放管理及调整追索机制。独立董事实行津贴制，非独立董事及高管薪酬与岗位、绩效、公司经营业绩挂钩，绩效薪酬占比不低于50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000036417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0229","BK0077","BK0132","BK0196","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628879741","title":"和邦生物最新公告：2025年净亏损5.36亿元同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2628879741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628879741?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:01","pubTimestamp":1776679263,"startTime":"0","endTime":"0","summary":"和邦生物(603077.SH)公告称，2025年实现营业收入71.88亿元，同比减少15.91%；归母净利润-5.36亿元，上年同期盈利3146.47万元，同比由盈转亏。报告期内，营业收入同比下降主要系受宏观经济及市场供需变化影响，本期公司联碱产品、玻璃及光伏产品、草甘膦产品销量和价格较上年同期下降；蛋氨酸产品和矿产品销售收入增长共同影响。注：公司Q4净利润-6.3亿，Q3净利润0.41亿，据此计算，Q4净利润由盈转亏。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000026676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","603077","BK0132","BK0229","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628746020","title":"和邦生物最新公告：拟投77.47亿元建设年产60万吨蛋氨酸项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2628746020","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628746020?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:41","pubTimestamp":1776678079,"startTime":"0","endTime":"0","summary":"和邦生物公告称，公司拟在四川省五通桥区工业园区投资建设60万吨/年绿色饲料级蛋氨酸及产业配套项目。项目总投资约77.47亿元，资金来源为自有资金及银行贷款。项目建设期预计24个月，主要建设60万吨/年饲料级液体蛋氨酸装置，并配套副产硫酸铵及丙烯酸装置。目前公司已取得立项批文，环评已公示，预计2027年10月开工。公司表示，该项目有助于提升规模效应和市场竞争力，但面临审批进度、财务支出及市场波动等风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000024780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0077","BK0132","BK0027","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628065746","title":"和邦生物最新公告：一季度净利润同比增长1287%蛋氨酸产、销量增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2628065746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628065746?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:40","pubTimestamp":1776678029,"startTime":"0","endTime":"0","summary":"和邦生物(603077.SH)公告称，2026年第一季度实现营业收入13.88亿元，同比下降19.58%；归属于上市公司股东的净利润为1.74亿元，同比增长1286.79%。业绩变动主要系本期公司产品双甘膦、草甘膦、蛋氨酸、氯化铵价格上涨，蛋氨酸产、销量增加，共同影响所致。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000024779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628756880","title":"每周股票复盘：和邦生物（603077）推7.91亿员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2628756880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628756880?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:12","pubTimestamp":1776532329,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，和邦生物报收于3.12元，较上周的2.95元上涨5.76%。本周，和邦生物4月17日盘中最高价报3.15元。交易信息汇总4月16日和邦生物发生一笔4101.45万元的大宗交易。会议审议通过了第四期员工持股计划相关议案。出席会议股东所持表决权股份占公司总股本的37.5351%。和邦生物发布第四期员工持股计划，拟筹集资金总额不超过7.91亿元，资金来源为员工合法薪酬。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0132","BK0229","BK0027","BK0196","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627029526","title":"4月16日和邦生物现4101.45万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2627029526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627029526?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:20","pubTimestamp":1776331233,"startTime":"0","endTime":"0","summary":"证券之星消息，4月16日和邦生物发生大宗交易，交易数据如下：大宗交易成交价格3元，成交1367.15万股，成交金额4101.45万元，买方营业部为中信证券股份有限公司总部，卖方营业部为中信证券股份有限公司四川分公司。近三个月该股共发生2笔大宗交易，合计成交14.28万手。该股近期无解禁股上市。截至2026年4月16日收盘，和邦生物报收于3.0元，上涨1.69%，换手率2.67%，成交量235.47万手，成交额7.05亿元。该股最近90天内无机构评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0077","BK0229","BK0132","BK0196","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627523898","title":"和邦生物（603077）披露2026年第一次临时股东会决议公告，4月15日股价下跌1.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627523898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627523898?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:04","pubTimestamp":1776261859,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，和邦生物报收于2.95元，较前一交易日下跌1.99%，最新总市值为260.53亿元。该股当日开盘3.01元，最高3.03元，最低2.93元，成交额达6.86亿元，换手率为2.62%。近日，四川和邦生物科技股份有限公司发布《2026年第一次临时股东会决议公告》。所有议案均获通过，无否决议案。出席会议股东所持表决权股份占公司总股本的37.5351%。北京国枫律师事务所对本次会议进行了见证并出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500042881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0027","BK0196","BK0132","BK0229","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625328616","title":"每周股票复盘：和邦生物（603077）担保总额达68亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2625328616","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625328616?lang=zh_cn&edition=full","pubTime":"2026-04-05 01:50","pubTimestamp":1775325018,"startTime":"0","endTime":"0","summary":"公司公告汇总：累计转股数量422,500股，占转股前公司总股本的0.0048%。股本变动后总股本为8,831,672,728股。2026年1月30日披露减持计划，拟于2026年3月2日至9月1日期间通过集中竞价交易方式减持已回购股份不超过176,630,744股，即不超过公司总股本的2%，所得资金用于补充项目流动资金。截至2026年3月31日，公司已减持23,400,000股，占公司总股本的0.26%，成交均价为3.11元/股，减持价格区间为2.82至3.35元/股，减持总金额为72,885,716.12元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0077","BK0027","BK0132","BK0196","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624507622","title":"和邦生物（603077）披露集中竞价减持已回购股份进展公告，4月2日股价下跌2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624507622","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624507622?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:20","pubTimestamp":1775139626,"startTime":"0","endTime":"0","summary":"和邦生物于近日披露《关于集中竞价减持已回购股份的进展公告》。2026年1月30日，公司披露减持计划，拟于2026年3月2日至9月1日期间通过集中竞价交易方式减持已回购股份不超过176,630,744股，即不超过公司总股本的2%，所得资金用于补充项目流动资金。截至2026年3月31日，公司已减持23,400,000股，占公司总股本的0.26%，成交均价为3.11元/股，减持价格区间为2.82至3.35元/股，减持总金额为72,885,716.12元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","603077","BK0196","BK0027","BK0132","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624599104","title":"和邦生物(603077.SH)：减持2340万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2624599104","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624599104?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:17","pubTimestamp":1775035021,"startTime":"0","endTime":"0","summary":"格隆汇4月1日丨和邦生物(603077.SH)公布，截至2026年3月31日，公司通过集中竞价交易方式减持已回购股份数量为2340万股，占公司总股本的比例为0.26%，成交均价为3.11元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260401/32118705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603077","BK0027","BK0077","BK0132","BK0196","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623387409","title":"每周股票复盘：和邦生物（603077）控股股东质押247百万股用于经营","url":"https://stock-news.laohu8.com/highlight/detail?id=2623387409","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623387409?lang=zh_cn&edition=full","pubTime":"2026-03-29 01:22","pubTimestamp":1774718531,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，和邦生物报收于2.86元，较上周的2.77元上涨3.25%。本周，和邦生物3月27日盘中最高价报2.92元。本周关注点公司公告汇总：控股股东和邦集团质押247,000,000股用于自身生产经营。本次变动后，和邦集团累计质押股份1,059,000,000股，占其持股总数53.93%，占公司总股本11.99%。和邦集团及其一致行动人贺正刚合计持有公司股份2,376,411,103股，占总股本26.91%，合并质押股份占其持股总数44.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","603077","BK0229","BK0132","BK0196","BK0027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778506497379,"stockEarnings":[{"period":"1week","weight":-0.0236},{"period":"1month","weight":0.007},{"period":"3month","weight":0.1844},{"period":"6month","weight":0.2565},{"period":"1year","weight":0.6609},{"period":"ytd","weight":0.2788}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川和邦生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"275201人(较上一季度增加36.39%)","perCapita":"32091股","listingDate":"2012-07-31","address":"四川省乐山市五通桥区牛华镇沔坝村","registeredCapital":"883169万元","survey":" 四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是联碱产品、矿产品、双甘膦/草甘膦、玻璃及光伏业务、蛋氨酸及副产品、生物农药、零售成品油、液氨、硫酸铵、天然气。","listedPrice":17.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和邦生物,603077,和邦生物股票,和邦生物股票老虎,和邦生物股票老虎国际,和邦生物行情,和邦生物股票行情,和邦生物股价,和邦生物股市,和邦生物股票价格,和邦生物股票交易,和邦生物股票购买,和邦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}